News and Studies Press Releases
Media Contact
Image Requests For use on authorized 3rd party websites, publications, and advertisements
Sections of this website require Adobe Reader and Flash Player
Press Releases
11.07 - PARI's eFlow included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation
10.07 - Study Using PARI Nebulizer Finds COPD Therapy of Nebulizer and Inhaler Combo More Effective than Inhaler Alone
10.07 - PARI Respiratory's LC Plus and PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday
09.07 - Pediatric Asthma Programs featuring PARI Pharma's eFlow Acquired by AstraZeneca
06.07 - PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
05.07 - PARI and Kamada
05.07 - Gilead's Phase III, PARI's eFlow Delivers
03.07 - PARI's Hydrate™ Receives FDA 510k Clearance
01/07 - PARI's eFlow® Wins Good Design Award
12/06 - NIH using PARI's eFlow® in HIV/AIDS Vaccine Research
11.06 - PARI's Hydrate™ to be Showcased at the AARC Congress
11/06 - PARI's eFlow® in Cystic Fibrosis Clinical Trial of L-arginine
11/06 - PARI and Kamada collaborate to Develop Inhaled alpha-1 Antitrypsin
10/06 - PARI's eFlow® Nebulizer used in Alnylam clinical Trial for Respiratory Syncytial Virus
10/06 - PARI's Trek and LC® Plus Deliver Sepracor's new COPD medication
9/06 - PARI Respiratory Launches Nasal Drug Delivery Program
9/06 - PARI Launches PRONEB® Ultra II Compressor
7/06 - PARI Launches LC® Plus Nebulizer and Trek® S Compact Compressor
6/06 - PARI & BOC in Collaboration to Develop Innovative Drug Delivery Systems
6/06 - PARI Celebrates 100 Years of Aerosol Delivery
6/06 - PARI Named Leading Nebulizer Company in Cambridge Consulting Survey
PARI Respiratory Equipment, Inc. | Tel: 1.800.FAST.NEB (327.8632) and 1.804.253.7274 | Fax: 1.800.727.4112 | Email: ProductInfo@PARI.com Website Design and Development by PARI Creative Services © 2008 PARI Respiratory Equipment, Inc. & PARI GmbH
